Document:

exv10w5

 

Exhibit 10.5

CONSULTING AGREEMENT

This Consulting Agreement (the “Agreement”) is entered into as of May 1, 2008 by and between
Perrigo Company, 515 Eastern Avenue, Allegan, MI (together with its affiliates, “Perrigo”), and
Moshe Arkin, 22 Derech Haganim, Kefar-Shmaryaho, Israel and M. Arkin Ltd. collectively referred to
as (“Arkin”).

WHEREAS Perrigo desires to retain Arkin to provide advice and consultation concerning Perrigo’s
generic prescription and API product selection and R&D efforts (the “Project”), and Arkin is
willing to be retained by Perrigo relative to the Project and to perform all consulting services on
a “best efforts” basis.

WHEREAS Perrigo and Arkin desire to make this Agreement relative to the Project effective as of
March 18, 2008 (the “Effective Date”).

NOW, THEREFORE, Perrigo and Arkin agree as follows:

	1	 	SCOPE OF ARRANGEMENT

	 	1.1	 	Perrigo engages Arkin, and Arkin accepts such engagement, to provide advice and
consultation to Perrigo regarding the Project.
	 
	 	1.2	 	During the Term (as defined below) of this Agreement, Arkin agrees to perform
the following services relative to the Project:

	 	•	 	Chair Perrigo’s Product Selection Committee for the generic
prescription drug business and provide advice, consultation and
direction relative to product selection for the Rx and API businesses;
	 
	 	•	 	provide advice and consultation concerning Perrigo’s R&D efforts
relative to the Generic Rx, API and Israeli – Pharma businesses;
	 
	 	•	 	provide advice and consultation relative to Perrigo’s strategic
initiatives; and
	 
	 	•	 	perform any other task or assignment as may be required or needed
relative to the Project.

	2	 	COMPENSATION AND ACCOUNTING

	 	2.1	 	During the Term, Perrigo agrees to pay Arkin, as full and complete
consideration for his advisory and consultation services relative to the Project, an
annual fee of $370,000 USD, payable in substantially equal monthly
installments. In
addition, Perrigo will reimburse Arkin for his reasonable and necessary expenses
related to the Project.

1

 

	 	2.2	 	Except for VAT the fee set forth in Section 2.1 includes all applicable taxes,
such as income tax, which shall be paid by Arkin. If Perrigo should be held liable to
pay such tax, then Perrigo may deduct and withhold the corresponding amount from the
fee otherwise payable to Arkin.

	3	 	COVENANTS

	 	3.1	 	Confidential Information.

	 	(i)	 	By reason of this Agreement and his service to Perrigo, Arkin
will have access to proprietary or confidential information, technical data,
trade secrets or know-how relating to Perrigo, in either oral, written, graphic
or electronic form, which may include, but is not limited to, market and product
research, business and technical information, scientific and experimental data,
patents and patent applications, licenses, manufacturing plans and equipment,
manufacturing processes, marketing plans and forecasts and other data relating
to the Project (collectively referred to as “Confidential Information”).
Confidential Information shall also include all notes, reports, analyses,
forecasts, compilations, studies, interpretations or other documents prepared by
Arkin that contain or reflect, in whole or in part, the information furnished to
Arkin pursuant to this Agreement. Arkin acknowledges that such Confidential
Information is a valuable and unique asset of Perrigo.
	 
	 	(ii)	 	For a period of five (5) years after either (a) the expiration or
termination of this Agreement pursuant to Section 6 below or (b) the termination
of Arkin’s service as a director on Perrigo’s Board of Directors, whichever is
later, Arkin covenants and agrees to keep the Confidential Information
confidential and, absent Perrigo’s prior written consent, not disclose any of
the Confidential Information in any manner whatsoever to any third party, unless
such information is in the public domain through no fault of Arkin or except as
may be required by law or in a judicial or administrative proceeding, in which
case Arkin will promptly inform Perrigo in writing of such required disclosure,
but in any event at least two business days prior to the disclosure.
Notwithstanding anything to the contrary in this Section 3.1, to the extent such
Confidential Information constitutes a trade secret of Perrigo, Arkin covenants
and agrees that the confidentiality obligation will continue until the trade
secret information enters into the public domain.
	 
	 	(iii)	 	Arkin may use the Confidential Information solely for the
purpose of the Project and this Agreement.
	 
	 	(iv)	 	At Perrigo’s request, or in the event this Agreement is
terminated for any reason by either party or expires as provided herein, Arkin
agrees to return to Perrigo and thereafter refrain from using all Confidential
Information and all
copies thereof. Arkin shall also destroy all information and materials he

2

 

	 	 	 	created or that were prepared on his behalf that contain or reference
Confidential Information. Notwithstanding Arkin’s return and destruction of
the Confidential Information, Arkin will continue to be bound by his
obligation of confidentiality as otherwise provided herein.

	 	3.2	 	Inventions and Patents. Arkin agrees that all inventions, innovations,
improvements, developments, methods, designs, analyses, drawings, reports and all
similar or related information that relate to Perrigo’s actual or anticipated business,
research and development or existing or future products or services and that are
conceived, developed or made by Arkin in the course of Arkin’s consulting for Perrigo
(“Work Product”) belong to Perrigo. Arkin will promptly disclose such Work Product to
the Company and perform all actions reasonably requested by Perrigo (whether during or
after the Term) to establish and confirm such ownership (including, without
limitations, assignments, consents, powers of attorney, and other instruments). To the
fullest extent permitted by applicable law, all intellectual property (including
patents, trademarks, and copyrights) which is made, developed or acquired by Arkin in
the course of Arkin’s consulting for Perrigo will be and remain the absolute property
of Perrigo, and Arkin shall assist Perrigo in perfecting and defending its rights to
such intellectual property. In addition, to the extent Arkin prepares any works for
Perrigo as a result of this Agreement, such works shall be expressly considered as
Works Made for Hire. Arkin assigns all right, title and interest, including all
copyrights (including reversionary rights) in such works to Perrigo. Perrigo shall not
be obligated to provide Arkin any additional consideration for his actions in
accordance with this paragraph beyond that provided for in Paragraph 2.1 of this
Agreement.
	 
	 	3.3	 	Non-Compete.

	 	(i)	 	In exchange for the consideration provided in this Agreement,
Arkin agrees that, during the Term and for a period of one year after the
expiration or termination of this Agreement, Arkin will not, except with the
prior written consent of Perrigo’s Board of Directors, directly or indirectly,
engage in Competition. For purposes of this Agreement, “Competition” means that
Arkin is employed by, or subject to Section 3.3(ii) below, provides consulting or other
substantial services to, any company that in any way sells, manufactures,
distributes or develops store brand and value brand over-the-counter
(OTC) drug or nutritional
products, topical generic prescription pharmaceutical products, active
pharmaceutical ingredients or any other products that Perrigo or one of its
affiliates is marketing or actively planning to market during the Term of this
Agreement or, with respect to the period after termination or expiration of this
Agreement, during the one year period ending on the one year anniversary of the
date of termination.
	 
	 	(ii)	 	Notwithstanding anything to the contrary in Section 3.3(i) above,
Arkin shall not be prohibited from (a) being a passive owner of not more than 5%
of the
outstanding stock or equity of any entity that is engaged in competition and

3

 

	 	 	 	that is publicly traded, so long as Arkin has no active participation in the
business of such entity, or (b) providing consulting or other substantial
services to companies described in Section 3.3(i) above, but only to the
extent that such services to not relate, directly or indirectly, to an OTC
drug or nutritional product, topical generic prescription pharmaceutical
product, or active pharmaceutical ingredient that Perrigo or one of its
affiliates is marketing or actively planning to market during the Term of
this Agreement, or to any other product that Perrigo or one of its affiliates
is marketing or actively planning to market during the Term of this Agreement
or, with respect to the period after termination or expiration of this
Agreement, during the one year period ending on the one year anniversary of
the date of termination.
	 
	 	(iii)	 	Arkin acknowledges that, as long as he serves as a member of
Perrigo’s Board of Directors, he has a fiduciary duty to Perrigo.

	 	3.4	 	Non-Solicitation. Arkin further covenants and agrees that, during the Term and
for the period of one year after the expiration or termination of this Agreement, he
will not, except with the prior written consent of Perrigo’s Board of Directors,
directly or indirectly, solicit for employment any person who was an employee of
Perrigo or an affiliate at any time during the Term for or on behalf of any employer
other than Perrigo or an affiliate for any position as an employee, independent
contractor, consultant or otherwise. Perrigo agrees that the term “solicit for
employment” shall not include general solicitations of employment not specifically
directed toward an employee, newspaper or other periodical advertisements, or general
searches conducted by professional recruiting firms.
	 
	 	3.5	 	Arkin acknowledges that Perrigo’s willingness to retain his services and
pay him as provided in this Agreement is expressly conditioned on Arkin’s undertaking
and complying with the requirements and restrictive covenants in this paragraph 3.
Arkin agrees that (i) the covenants set forth in this paragraph 3 are reasonable in all
respects, including, where applicable, geographical and temporal scope, and (ii)
Perrigo and Arkin would not have entered into this Agreement but for Arkin’s and
Perrigo’s covenants contained, and (iii) the covenants contained have been made in
order to induce Perrigo and Arkin to enter into this Agreement.

	4	 	TERM AND TERMINATION

	 	4.1	 	This Agreement shall become effective as of the Effective Date and shall remain
in effect for a period of twelve (12) months (the “Term”). Thereafter, this Agreement
shall automatically be extended for additional 12-month periods unless either party to
this Agreement provides written notice of non-renewal to the other party at least 90
days before the last day of the Term. The term “Term” shall also include any renewal
period under the foregoing provisions of this paragraph 4.1.

4

 

	 	4.2	 	Either party may terminate this Agreement for any reason prior to its natural
expiration by that party giving ninety (90) days prior written notice of termination to
the other party.
	 
	 	4.3	 	If either Perrigo or Arkin materially breaches any of the terms of this
Agreement, the other party shall have the right to terminate this Agreement with
immediate effect upon written notice.
	 
	 	4.4	 	The provisions of Sections 3 and 4 shall survive any early termination for a
period of three (3) years from the date of such termination.
	 
	 	4.5	 	This Agreement shall be governed by the laws of the State of Israel without
regard to principals of conflict of laws.

	5	 	MISCELLANEOUS PROVISIONS

	 	5.1	 	Arkin’s relationship with Perrigo is as an independent contractor. Nothing in
this Agreement shall create an employment or agency relationship, nor shall Arkin act
as an agent or employee of Perrigo unless such representation is specifically provided
for herein or in writing by Perrigo.
	 
	 	5.2	 	Notices and all other communications provided for in this Agreement shall be in
writing and shall be delivered personally or sent by registered or certified mail,
return receipt requested, postage pre-paid or sent by facsimile or prepaid overnight
courier to the parties at the addresses set forth below (or such other addresses as
shall be specified by the parties by like notice):
	 
	 	 	 	Perrigo:

Perrigo Company

515 Eastern Avenue

Allegan, MI 49010

Attn: General Counsel

Copy to Director of Human Resources

Arkin:

Moshe Arkin

22 Derech Haganim

Kefar-Shmaryaho, Israel

	 	5.3	 	This Agreement contains the entire agreement between the parties relative to
the Project and supersedes all prior agreements and understandings, written or
otherwise, related to the Project. This Agreement may not be modified or waived, in
whole or in part, unless agreed to in writing by both parties.

5

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
written.

	 	 	 
	PERRIGO COMPANY

	 	MOSHE ARKIN
	 
	 	 
	By: /s/ Joseph C. Papa

	 	By: /s/ Moshe Arkin
	 

	 	 
	Joseph C. Papa

	 	Moshe Arkin
	President and Chief Executive Officer
	 	 

6exv10w1w9

 

Exhibit 10.1.9

WESTERN DIGITAL CORPORATION

AMENDED AND RESTATED 2004 PERFORMANCE INCENTIVE PLAN

NON-EMPLOYEE DIRECTOR OPTION GRANT PROGRAM

1. Establishment; Purpose. This Non-Employee Director Option Grant Program (this
“Program”) is adopted under the Western Digital Corporation Amended and Restated 2004 Performance
Incentive Plan (the “Plan”). The purpose of this Program is to promote the success of the
Corporation and the interests of its stockholders by providing members of the Board who are not
officers or employees of the Corporation or one of its Subsidiaries (“Non-Employee Directors”) an
opportunity to acquire an ownership interest in the Corporation and more closely aligning the
interests of Non-Employee Directors and stockholders. Except as otherwise expressly provided
herein, the provisions of the Plan shall govern all awards made pursuant to this Program.
Capitalized terms are defined in the Plan if not defined herein.

2. Participation. Awards under this Program shall be made only to Non-Employee Directors,
shall be evidenced by award agreements substantially in the form of Exhibit 1 hereto and shall be
further subject to such other terms and conditions set forth therein.

3. Option Grants.

     3.1 Initial Award for New Non-Employee Directors.

     3.1.1 Upon or as soon as reasonably practicable after first being appointed or elected
to the Board and subject to approval by the Board or the Administrator, a Non-Employee
Director who has not previously served on the Board shall be granted a nonqualified stock
option to purchase a number of shares of Common Stock that produces an approximate value for
the option grant equal to $300,000 (using a Black-Scholes valuation as of the time of grant
as determined in consultation with Company management and based on the Fair Market Value of
a share of Common Stock on the trading day immediately preceding the grant date of the stock
option); provided, however, that the Board or the Administrator, in its discretion, may at
the time of grant of the award increase or decrease the number of shares of Common Stock
otherwise subject to the stock option. The date of grant of each such stock option will be
the date on which such stock option is approved by the Board or the Administrator, which
date shall coincide to the extent practicable with the date such Non-Employee Director is
first appointed or elected to the Board.

     3.1.2 Each member of the Board who was previously an employee of the Corporation or any
of its Subsidiaries who first becomes a Non-Employee Director by virtue of retiring or
otherwise ceasing to be employed by the Corporation or any of its Subsidiaries shall, upon
or as soon as reasonably practicable after the date that he or she is first a Non-Employee
Director, be granted a nonqualified stock option to purchase a number of shares of Common
Stock that produces an approximate value for the option grant (using a Black-Scholes
valuation as of the time of grant as determined in consultation with Company management and
based on the Fair Market Value of a share of Common Stock on the trading day immediately
preceding the grant date of the stock option) of (i) $100,000, divided by (ii) 365,
multiplied by (iii) the number of days from

1

 

the date such person is first a Non-Employee Director to the anticipated date of the
Corporation’s next annual meeting of stockholders; provided, however, that the Board or the
Administrator, in its discretion, may at the time of grant of the award increase or decrease
the number of shares of Common Stock otherwise subject to the stock option. The date of
grant of each such stock option will be the date on which such stock option is approved by
the Board or the Administrator, which date shall coincide to the extent practicable with the
date such person first becomes a Non-Employee Director.

3.2 Subsequent Awards. Immediately following the Corporation’s regular annual meeting of
stockholders in each year during the term of the Plan commencing in 2005 and subject to
approval by the Board or the Administrator, each Non-Employee Director then in office shall
be granted a nonqualified stock option to purchase a number of shares of Common Stock that
produces an approximate value for the option grant equal to $100,000 (using a Black-Scholes
valuation as of the time of grant as determined in consultation with Company management and
based on the Fair Market Value of a share of Common Stock on the trading day immediately
preceding the grant date of the stock option); provided, however, that the Board or the
Administrator, in its discretion, may at the time of grant of the award increase or decrease
the number of shares of Common Stock otherwise subject to the stock option. The date of
grant of each such stock option will be the date on which such stock option is approved by
the Board or the Administrator, which date shall coincide to the extent practicable with the
date of the annual meeting of stockholders. An individual who was previously a member of
the Board, who then ceased to be a member of the Board for any reason, and who then again
becomes a Non-Employee Director shall thereupon again become eligible to be granted stock
options under this Section 3.2.

3.3 Option Price. The purchase price per share of the Common Stock covered by each option
granted pursuant to this Section 3 shall be 100 percent of the Fair Market Value of a share
of Common Stock on the date of grant of the option (the “Award Date”). The exercise price
of any option granted under this Section 3 shall be paid in full at the time of each
purchase in cash or by check, in shares of Common Stock valued at their fair market value on
the date of exercise of the option, or partly in such shares and partly in cash, or in any
other manner authorized by the Administrator pursuant to Section 5.5 of the Plan; provided
that any shares used in payment shall have been owned by the Non-Employee Director for at
least six months prior to the date of exercise.

3.4 Transfer Restrictions. Options granted pursuant to this Section 3 shall be subject to
the transfer restrictions set forth in Section 5.7 of the Plan. For purposes of clarity,
the Administrator has not approved any transfer exceptions with respect to the options in
accordance with Section 5.7.2 of the Plan.

4. Option Period and Exercisability. Each option granted under Section 3 above and all
rights or obligations under this Program with respect to a particular option shall expire seven
years after the date of grant of such option and shall be subject to earlier termination as
provided below. Subject to Sections 5, 6 and 7 hereof, each option granted under Section 3 shall
become exercisable as to 25% of the total number of shares subject thereto on the first anniversary
of the

2

 

date of grant of the option and as to an additional 6.25% of the total number of shares subject
thereto at the end of each of the next 12 three-month periods thereafter.

5. Termination of Directorship. Subject to the maximum seven-year term of the option and
subject to earlier termination pursuant to Section 7 below, if a Non-Employee Director ceases to be
a member of the Board for any reason, the following rules shall apply with respect to any option
granted to the Non-Employee Director pursuant to Section 3 above (the last day that the Director is
a member of the Board is, except as otherwise provided below, referred to as the Director’s
“Severance Date”):

	 	•	 	other than as expressly provided below in this Section 5, (a) the Non-Employee
Director will have until the date that is one (1) year after his or her Severance Date
to exercise such option (or portion thereof) to the extent that it was vested on the
Severance Date, (b) such option, to the extent not vested on the Severance Date, shall
terminate on the Severance Date, and (c) such option, to the extent exercisable for the
one-year period following the Severance Date and not exercised during such period,
shall terminate at the close of business on the last day of the one-year period;
	 
	 	•	 	if the Non-Employee Director ceases to be a member of the Board due to his or her
Retirement (as defined below) and the Non-Employee Director has served as a member of
the Board of Directors for at least twelve (12) continuous months following the grant
date of such option, (a) the Non-Employee Director will have until the date that is
three (3) years after his or her Severance Date to exercise such option, (b) such
option, to the extent not otherwise vested on the Severance Date, shall automatically
become fully vested as of the Severance Date, and (c) such option, to the extent
exercisable for the three-year period following the Severance Date and not exercised
during such period, shall terminate at the close of business on the last day of the
three-year period;

provided, however, that if the Board or the Administrator determines that any such Non-Employee
Director who has Retired renders services as an employee, director, consultant, contractor or
otherwise to a competitor of the Corporation or one of its Subsidiaries at any time during such
three-year period, then any such option shall immediately terminate to the extent not exercised as
of the date the Board or the Administrator makes such determination. In addition, in such event
the Corporation shall have the right to recover any profits realized by such Retired Non-Employee
Director as a result of any exercise of such option during the six-month period prior to the date
such Non-Employee Director commenced providing such services to a competitor.

     For purposes of this Section 5, the term “Retirement” (which term shall include “Retired”)
shall mean the cessation of a director’s services as a member of the Board due to his or her
voluntary resignation at any time after such director has served as a member of the Board for at
least forty-eight (48) months.

     Notwithstanding any other provision of this Section 5, if a Non-Employee Director ceases to be
a member of the Board (regardless of the reason) but, immediately thereafter, is

3

 

employed by the Corporation or one of its Subsidiaries, such director’s Severance Date shall not be
the date the director ceases to be a member of the Board but instead shall be the last day that the
director is either or both (1) a member of the Board and/or (2) employed by the Corporation or a
Subsidiary.

6. Adjustments. Options granted under this Program shall be subject to adjustment as
provided in Section 7.1 of the Plan, but only to the extent that such adjustment is consistent with
adjustments to options held by persons other than executive officers or directors of the
Corporation (to the extent that persons other than executive officers or directors of the
Corporation then hold options). The grant levels reflected in Section 3 above shall be
automatically adjusted upon the record date for any stock split, reverse stock split, or stock
dividend to give effect to such change in capitalization unless otherwise provided by the Board or
the Administrator in the circumstances, and may be adjusted in the discretion of the Board or the
Administrator in any other circumstances contemplated by Section 7.1.

7. Acceleration and Possible Early Termination. If a Change in Control Event (as such term
is defined in the Plan) occurs and in connection with such Change in Control Event a Non-Employee
Director ceases to be a member of the Board, each option granted under Section 3 above to such
Non-Employee Director, to the extent such option is then outstanding, shall become immediately
exercisable and vested in full. For purposes of this Section 7, but without limitation, a director
will be deemed to have ceased to be a member of the Board in connection with a Change in Control
Event if such director (a) is removed by or resigns upon the request of any Person exercising
practical voting control over the Corporation following such Change in Control Event or a person
acting upon authority or at the instruction of such Person, or (b) is willing or able to continue
as a member of the Board but is not re-elected to or retained as a member of the Board by the
Corporation’s stockholders at the stockholder vote or consent action for the election of directors
that precedes and is taken in connection with, or next follows, such Change in Control Event.

     Each option granted under this Program shall be subject to adjustment and termination pursuant
to Section 7 of the Plan.

8. Maximum Number of Shares; Amendment; Administration. If option grants otherwise
required pursuant to this Program would otherwise exceed any applicable share limit under Section
4.2 of the Plan, such grants shall be made pro-rata to directors entitled to such grants. The
Board or the Administrator may from time to time amend this Program without stockholder approval;
provided that no such amendment shall materially and adversely affect the rights of a Non-Employee
Director as to an option granted under this Program before the adoption of such amendment. This
Program does not limit the authority of the Board or the Administrator to make other,
discretionary award grants to Non-Employee Directors pursuant to the Plan. The Plan
Administrator’s power and authority to construe and interpret the Plan and awards thereunder
pursuant to Section 3.1 of the Plan shall extend to this Program and awards granted hereunder. As
provided in Section 3.2 of the Plan, any action taken by, or inaction of, the Administrator
relating or pursuant to this Program and within its authority or under applicable law shall be
within the absolute discretion of that entity or body and shall be conclusive and binding upon all
persons.

4

 

###

As amended (Sections 3.1 and 3.2) and restated November 17, 2005

As amended (Section 5) November 9, 2006

As amended (Sections 3.1 and 3.2) August 22, 2007

As amended (Sections 4 and 5) November 5, 2007

5

 

EXHIBIT 1

Western Digital Corporation 20511 Lake Forest Drive

Lake Forest, California 92630 Telephone 949-672-7000

Notice Of Grant Of Stock Option

and Option Agreement — Non-Employee Directors

«fn» «mn» «ln»

«ad1»

«ad2»

«ad3»

«cty», «st» «z»

Western Digital Corporation (the “Corporation”) has granted to you (the “Participant”), effective
on the Date of Grant set forth below, a nonqualified option to purchase shares of the Corporation’s
Common Stock (the “Option”) as follows:

	 	 	 	 	 
	 

	 	Grant Number
	 	«nbr»
	 

	 	Date of Grant
	 	«optdt»
	 

	 	Option Price per Share 1
	 	$«optprc»
	 

	 	Number of Shares Granted1
	 	«shgtd»
	 

	 	Expiration Date2	 	 

1. Option Subject to Amended and Restated 2004 Performance Incentive Plan. The Option was granted
pursuant to the Non-Employee Director Option Grant Program (the “Program”), adopted under the
Western Digital Corporation Amended and Restated 2004 Performance Incentive Plan (the “Plan”). The
Option is subject to the terms and conditions of this Notice, the Program and the Plan. By
accepting the Option, you are agreeing to the terms of the Option as set forth in these documents.
A copy of each of these documents has been provided to you. If you need another copy of any of
these documents, or if you would like to confirm that you have the most recent version, you may
obtain another copy in the Company Library on the E*TRADE Stock Plans web site. The documents are
also available on the Western Digital Intranet site under Legal.

You should read the Program, the Plan, the Prospectus for the Plan and this Notice. The Program
and the Plan are each incorporated into (made a part of) this Notice by this reference. To the
extent any information in this Notice, the Prospectus for the Plan, or other information provided
by the Corporation conflicts with the Program and/or the Plan, the Program or the Plan, as
applicable, shall control. Capitalized terms not defined herein have the meanings set forth in the
Plan.

You do not have to accept the Option. If you do not agree to the terms of the Option, you should
promptly return this Notice to the Western Digital Corporation Stock Plans Administrator.

 

			
	1	 	The number of shares subject to the Option and the
per-share exercise price of the Option are subject to adjustment under Section
6 of the Program and Section 7.1 of the Plan (for example, and without
limitation, in connection with stock splits).
	 
	2	 	The Option is subject to early termination under
Sections 5 and 7 of the Program.

 

 

Unless otherwise expressly provided in other sections of this Notice, provisions of the Plan that
confer discretionary authority on the Board or the Administrator do not and shall not be deemed to
create any rights in the Participant unless such rights are expressly set forth herein or are
otherwise in the sole discretion of the Board or the Administrator so conferred by appropriate
action of the Board or the Administrator under the Plan after the grant date of the Option.

2. Option Agreement. This Notice constitutes the Option Agreement with respect to the
Option pursuant to Section 5.3 of the Plan.

3. Type of Stock Option. The Option is not intended to qualify as an incentive stock
option under Section 422 of the Internal Revenue Code of 1986, as amended.

4. Vesting. Subject to earlier termination in accordance with Section 5, the Option shall
vest and become exercisable in percentage installments of the aggregate number of shares
subject to the Option as set forth in this Notice and Section 4 of the Program. The Option
may be exercised only to the extent it is vested and exercisable. To the extent that the
Option is vested and exercisable, the Participant has the right to exercise the Option (to
the extent not previously exercised), and such right shall continue, until the expiration
or earlier termination of the Option as provided in Section 5. Fractional share interests
shall be disregarded, but may be cumulated.

The vesting schedule requires continued service through each applicable vesting date as a condition
to the vesting of the applicable installment of the Option and the rights and benefits under this
Option Agreement. Service for only a portion of the vesting period with respect to a vesting
installment, even if services are provided for a substantial portion of that period, will not
entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights
and benefits upon or following a termination of services as provided under Section 5 of the Program
or under the Plan.

5. Expiration of Option. The Option shall expire and the Participant shall have no further rights
with respect thereto upon the earliest to occur of (a) the termination of the Option in connection
with a termination of the director’s services as provided in Section 5 of the Program, (b) the
termination of the Option as provided in Section 7.4 of the Plan, or (c) the Expiration Date set
forth in this Notice. The Option may not be exercised at any time after a termination or
expiration of the Option.

6. Exercise of Option. The Option shall be exercisable by the delivery to the Secretary of the
Corporation (or such other person as the Administrator may require pursuant to such administrative
exercise procedures as the Administrator may implement from time to time) of:

	 	•	 	a written notice stating the number of shares of Common Stock to be purchased
pursuant to the Option or by the completion of such other administrative exercise
procedures as the Administrator may require from time to time,
	 
	 	•	 	payment in full for the purchase price (the per-share exercise price of the Option
multiplied by the number of shares to be purchased) in cash, check or by electronic
funds transfer to the Corporation, or (subject to compliance with all applicable laws,
rules, regulations and listing requirements and further subject to such rules as the
Administrator may adopt as to any non-cash payment) in shares of Common Stock already
owned by the Participant, valued at their fair market value on the exercise date,
provided, however, that any shares initially acquired upon exercise of
a stock option or otherwise from the Corporation must have been owned by the
Participant for at least six (6) months before the date of such exercise; and

 

 

	 	•	 	any written statements or agreements required by the Administrator pursuant to
Section 8.1 of the Plan.

The Administrator also may, but is not required to, authorize a non-cash payment alternative by
notice and third party payment in such manner as may be authorized by the Administrator.

7. Nontransferability. The Option and any other rights of the Participant under this Option
Agreement, the Program or the Plan are nontransferable and exercisable only by the Participant,
except as set forth in Section 5.7 of the Plan. For purposes of clarity, the Administrator has not
authorized any transfer exceptions as contemplated by Section 5.7.2 of the Plan.

8. No Service Commitment. Nothing contained in this Option Agreement, the Program or the Plan
constitutes an employment or service commitment by the Corporation or any of its Subsidiaries,
confers upon the Participant any right to remain in service to the Corporation or any Subsidiary,
interferes in any way with the right of the Corporation or any Subsidiary at any time to terminate
such service, or affects the right of the Corporation or any Subsidiary to increase or decrease the
Participant’s other compensation.

9. Rights as a Stockholder. Neither the Participant nor any beneficiary or other person claiming
under or through the Participant shall have any right, title, interest or privilege in or to any
shares of Common Stock subject to the Option except as to such shares, if any, as shall have been
actually issued to such person and recorded in such person’s name following the exercise of the
Option or any portion thereof.

10. Notices. Any notice to be given under the terms of this Option Agreement shall be in writing
and addressed to the Corporation at its principal office to the attention of the Secretary, and to
the Participant at the address last reflected on the Corporation’s records, or at such other
address as either party may hereafter designate in writing to the other. Any such notice shall be
delivered in person or shall be enclosed in a properly sealed envelope addressed as aforesaid,
registered or certified, and deposited (postage and registry or certification fee prepaid) in a
post office or branch post office regularly maintained by the United States Government. Any such
notice shall be given only when received, but if the Participant is no longer a member of the Board
of Directors, shall be deemed to have been duly given five business days after the date mailed in
accordance with the foregoing provisions of this Section 10.

11. Arbitration. Any controversy arising out of or relating to this Option Agreement, the Program
and/or the Plan, their enforcement or interpretation, or because of an alleged breach, default, or
misrepresentation in connection with any of their provisions, or any other controversy or claim
arising out of or related to the Option or the Participant’s employment, including, but not limited
to, any state or federal statutory claims, shall be submitted to arbitration in Orange County,
California, before a sole arbitrator selected from Judicial Arbitration and Mediation Services,
Inc., Orange, California, or its successor (“JAMS”), or if JAMS is no longer able to supply the
arbitrator, such arbitrator shall be selected from the American Arbitration Association, and shall
be conducted in accordance with the provisions of California Code of Civil Procedure §§ 1280 et
seq. as the exclusive forum for the resolution of such dispute; provided, however, that provisional
injunctive relief may, but need not, be sought by either party to this Option Agreement in a court
of law while arbitration proceedings are pending, and any provisional injunctive relief granted by
such court shall remain effective until the matter is finally determined by the arbitrator. Final
resolution of any dispute through arbitration may include any remedy or relief which the arbitrator
deems just and equitable, including any and all remedies provided by applicable state or federal
statutes. At the conclusion of the arbitration, the arbitrator shall issue a written decision that
sets forth the essential findings and conclusions upon which the arbitrator’s award or decision is
based. Any award or relief granted by the arbitrator hereunder shall be final and binding on

 

 

the parties hereto and may be enforced by any court of competent jurisdiction. The parties
acknowledge and agree that they are hereby waiving any rights to trial by jury in any action,
proceeding or counterclaim brought by either of the parties against the other in connection with
any matter whatsoever arising out of or in any way connected with any of the matters referenced in
the first sentence above. The parties agree that Corporation shall be responsible for payment of
the forum costs of any arbitration hereunder, including the arbitrator’s fee. The parties further
agree that in any proceeding with respect to such matters, each party shall bear its own attorney’s
fees and costs (other than forum costs associated with the arbitration) incurred by it or him or
her in connection with the resolution of the dispute. By accepting the Option, the Participant
consents to all of the terms and conditions of this Option Agreement (including, without
limitation, this Section 11).

12. Governing Law. This Option Agreement shall be interpreted and construed in accordance with the
laws of the State of Delaware (without regard to conflict of law principles thereunder) and
applicable federal law.

13. Severability. If the arbitrator selected in accordance with Section 11 or a court of competent
jurisdiction determines that any portion of this Option Agreement, the Program or the Plan is in
violation of any statute or public policy, then only the portions of this Option Agreement, the
Program or the Plan, as applicable, which are found to violate such statute or public policy shall
be stricken, and all portions of this Option Agreement, the Program and the Plan which are not
found to violate any statute or public policy shall continue in full force and effect.
Furthermore, it is the parties’ intent that any order striking any portion of this Option
Agreement, the Program and/or the Plan should modify the stricken terms as narrowly as possible to
give as much effect as possible to the intentions of the parties hereunder.

14. Entire Agreement. This Option Agreement, the Program and the Plan together constitute the
entire agreement and supersede all prior understandings and agreements, written or oral, of the
parties hereto with respect to the subject matter hereof. The Plan, the Program and this Option
Agreement may be amended pursuant to Section 8.6 of the Plan. Such amendment must be in writing
and signed by the Corporation. The Corporation may, however, unilaterally waive any provision
hereof in writing to the extent such waiver does not adversely affect the interests of the
Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent
waiver of the same provision or a waiver of any other provision hereof.

15. Section Headings. The section headings of this Option Agreement are for convenience of
reference only and shall not be deemed to alter or affect any provision hereof.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00141-of-00352.parquet"}]]